IDXX - Company ID 0000874716
IDEXX LABORATORIES INC /DE (IDXX) reported net income of $1.06B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $1.06B | +19.3% |
| FY 2024 | $887.87M | +5.1% |
| FY 2023 | $845.04M | +24.4% |
| FY 2022 | $679.09M | -8.8% |
| FY 2021 | $744.85M | +28.0% |
| FY 2020 | $581.78M | +36.0% |
| FY 2019 | $427.72M | +13.4% |
| FY 2018 | $377.03M | +43.3% |
| FY 2017 |
IDEXX LABORATORIES INC /DE (IDXX) reported net income of $1.06B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, IDEXX LABORATORIES INC /DE's net income grew from $161.79M to $1.06B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $263.14M |
| +18.5% |
| FY 2016 | $222.04M | +15.6% |
| FY 2015 | $192.08M | +5.6% |
| FY 2014 | $181.91M | -3.1% |
| FY 2013 | $187.80M | +5.3% |
| FY 2012 | $178.27M | +10.2% |
| FY 2011 | $161.79M | - |